These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34023130)

  • 1. Neuroendocrine tumors of the gynecologic tract update.
    Winer I; Kim C; Gehrig P
    Gynecol Oncol; 2021 Jul; 162(1):210-219. PubMed ID: 34023130
    [No Abstract]   [Full Text] [Related]  

  • 2. [Contemporary management of neuroendocrine neoplasms of the female genital organs].
    Kuc-Rajca M; Dańska-Bidzińska A
    Ginekol Pol; 2011 Sep; 82(9):685-9. PubMed ID: 22379929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Update of Neuroendocrine Tumors of the Female Reproductive System.
    Kefeli M; Usubütün A
    Turk Patoloji Derg; 2015; 31 Suppl 1():128-44. PubMed ID: 26177323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document.
    Gardner GJ; Reidy-Lagunes D; Gehrig PA
    Gynecol Oncol; 2011 Jul; 122(1):190-8. PubMed ID: 21621706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine tumours of the gynecological tract.
    Reed NS
    Curr Opin Oncol; 2016 Sep; 28(5):412-8. PubMed ID: 27467970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare Gynecologic Tumors: Coming of Age.
    Gershenson DM; Okamoto A; Ray-Coquard I
    Gynecol Oncol; 2020 Apr; 157(1):1-2. PubMed ID: 32241340
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
    Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
    Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine tumors.
    Kulke MH; Benson AB; Bergsland E; Berlin JD; Blaszkowsky LS; Choti MA; Clark OH; Doherty GM; Eason J; Emerson L; Engstrom PF; Goldner WS; Heslin MJ; Kandeel F; Kunz PL; Kuvshinoff BW; Moley JF; Pillarisetty VG; Saltz L; Schteingart DE; Shah MH; Shibata S; Strosberg JR; Vauthey JN; White R; Yao JC; Freedman-Cass DA; Dwyer MA;
    J Natl Compr Canc Netw; 2012 Jun; 10(6):724-64. PubMed ID: 22679117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroendocrine Tumors].
    Jantze A; Haller C; Delaloye R
    Praxis (Bern 1994); 2016 Jan; 105(1):7-12; quiz 13-4. PubMed ID: 26732711
    [No Abstract]   [Full Text] [Related]  

  • 10. The North American Neuroendocrine Tumor Society (NANETS) guidelines: mission, goals, and process.
    Kvols LK; Brendtro KL;
    Pancreas; 2010 Aug; 39(6):705-6. PubMed ID: 20664469
    [No Abstract]   [Full Text] [Related]  

  • 11. The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors.
    Halfdanarson TR; Strosberg JR; Tang L; Bellizzi AM; Bergsland EK; O'Dorisio TM; Halperin DM; Fishbein L; Eads J; Hope TA; Singh S; Salem R; Metz DC; Naraev BG; Reidy-Lagunes DL; Howe JR; Pommier RF; Menda Y; Chan JA
    Pancreas; 2020 Aug; 49(7):863-881. PubMed ID: 32675783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Therapeutic Concepts and Latest Diagnostic Advancements Regarding Neuroendocrine Tumors of the Gynecologic Tract.
    Georgescu TA; Bohiltea RE; Munteanu O; Furtunescu F; Lisievici AC; Grigoriu C; Gherghiceanu F; Vlădăreanu EM; Berceanu C; Ducu I; Iordache AM
    Medicina (Kaunas); 2021 Dec; 57(12):. PubMed ID: 34946283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine tumors of the gynecologic tract: select topics.
    Rouzbahman M; Clarke B
    Semin Diagn Pathol; 2013 Aug; 30(3):224-33. PubMed ID: 24144291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroendocrine tumors of the gastrointestinal tract].
    Arnold C
    Praxis (Bern 1994); 2007 Jan; 96(1-2):19-28. PubMed ID: 17256557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NETTER-1 Phase III in Patients With Midgut Neuroendocrine Tumors Treated With 177Lu-DOTATATE: Efficacy and Safety Results.
    Clin Adv Hematol Oncol; 2016 May; 14(5 Suppl 7):8-9. PubMed ID: 27168104
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pathological implications in the neuroendocrine gastrointestinal system].
    Piette C; Polus M; Louis E
    Rev Med Liege; 2002 Aug; 57(8):509-18. PubMed ID: 12405024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management guidelines for gastrointestinal neuroendocrine neoplasm.
    Kos-Kudła B
    Endokrynol Pol; 2013; 64(6):V-VI. PubMed ID: 24575442
    [No Abstract]   [Full Text] [Related]  

  • 18. GASTRIC NEUROENDOCRINE TUMOR: REVIEW AND UPDATE.
    Dias AR; Azevedo BC; Alban LBV; Yagi OK; Ramos MFKP; Jacob CE; Barchi LC; Cecconello I; Ribeiro U; Zilberstein B
    Arq Bras Cir Dig; 2017; 30(2):150-154. PubMed ID: 29257854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized Controlled Trials in Neuroendocrine Tumors.
    McAuliffe JC; Wolin EM
    Surg Oncol Clin N Am; 2017 Oct; 26(4):751-765. PubMed ID: 28923229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine tumour management: a team approach.
    Banfield A; Green S; Ramage JK
    Hosp Med; 2005 Jan; 66(1):37-42. PubMed ID: 15686165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.